Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
ABSTRACT: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual glucose-dependent insulinotropic polypeptide/GLP-1 RAs are common therapies for managing diabetes and obesity, but gastrointestinal (GI) adverse effects (AEs) such as nausea, vomiting, diarrhea, and constipation frequently limit therapy
Trusted treatment designed for those who settle for nothing less than excellence
Hansen MK et al
2) Real-world readiness: Pay attention to evidence on persistence, access, and health equity
Product Details Form: Lyophilized powder (for laboratory research) Amount: 10 mg per vial Purity: 98% (HPLC tested) Sequence: Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH (13 amino acids) Molecular Formula: CHNO Molecular Weight: ~1646.9 g/mol Intended Use: Laboratory research only DISCLAIMER: This product is strictly to be used for scientific research use only
US$ 20.67
US$ 26.38
US$ 20.32
US$ 29.27
US$ 24.25
US$ 24.77
